Literature DB >> 19171992

Diffuse cutaneous leishmaniasis: co-infection with human immunodeficiency virus (HIV).

Raju G Chaudhary1, Freny E Bilimoria, S K Katare.   

Abstract

Cutaneous leishmaniasis is a disease caused by intracellular protozoal parasites belonging to the genus Leishmania. Immune suppression caused by HIV infection is an important factor for atypical presentation and widespread progression of cutaneous leishmaniasis. Diffuse (disseminated) cutaneous leishmaniasis and HIV co-infection is emerging as an extremely serious new disease. A 38-year-old HIV-positive man presented with a 12-month history of a progressive papule and nodular eruptions on face and extremities with infiltrations of nasal and oral mucosa. We report the case due to its atypical, widespread muco-cutaneous presentation masquerading as lepromatous leprosy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19171992     DOI: 10.4103/0378-6323.45111

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  16 in total

1.  Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia.

Authors:  Tesfaye Gelanew; Zewdu Hurissa; Ermias Diro; Aysheshm Kassahun; Katrin Kuhls; Gabriele Schönian; Asrat Hailu
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  A patient presenting with diffuse cutaneous leishmaniasis (DCL) as a first indicator of HIV infection in India.

Authors:  Kanika Khandelwal; Ram Awatar Bumb; Rajesh Dutt Mehta; Himanshu Kaushal; Claudio Lezama-Davila; Poonam Salotra; Abhay R Satoskar
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

3.  Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion.

Authors:  Zhirong Mou; Helen M Muleme; Dong Liu; Ping Jia; Ifeoma B Okwor; Shiby M Kuriakose; Stephen M Beverley; Jude E Uzonna
Journal:  J Immunol       Date:  2013-03-04       Impact factor: 5.422

4.  Disseminated Autochthonous Dermal Leishmaniasis Caused by Leishmania siamensis (PCM2 Trang) in a Patient from Central Thailand Infected with Human Immunodeficiency Virus.

Authors:  Chavalit Supsrisunjai; Tanawatt Kootiratrakarn; Pailin Puangpet; Thareena Bunnag; Prapaipit Chaowalit; Vesarat Wessagowit
Journal:  Am J Trop Med Hyg       Date:  2017-01-30       Impact factor: 2.345

5.  Epidemiological features of cutaneous leishmaniasis endemic in hilly areas of district Karak, Khyber-Pakhtunkhwa province of Pakistan.

Authors:  Mehboob Nawaz; Misbahud Din; Ayyaz Khan; Asad Khan; Muhammad Ali; Siraj Ud Din; Khalid Aslam
Journal:  J Parasit Dis       Date:  2020-07-23

6.  Old World cutaneous leishmaniasis: diagnosis and treatment.

Authors:  Abderrahmen Masmoudi; Wala Hariz; Slaheddine Marrekchi; Mariem Amouri; Hamida Turki
Journal:  J Dermatol Case Rep       Date:  2013-06-30

7.  Human immunodeficiency virus and leishmaniasis.

Authors:  Navid Ezra; Maria Teresa Ochoa; Noah Craft
Journal:  J Glob Infect Dis       Date:  2010-09

8.  Post-kala-azar dermal leishmaniasis in HIV-positive patients: A study of two cases.

Authors:  Sejal Shah; Aditya Shah; Sachin Prajapati; Freny Bilimoria
Journal:  Indian J Sex Transm Dis AIDS       Date:  2010-01

Review 9.  PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.

Authors:  Eduard E Zijlstra
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

10.  Case Report: Coinfection by Leishmania amazonensis and HIV in a Brazilian Diffuse Cutaneous Leishmaniasis Patient.

Authors:  Gustavo Henrique Corrêa Soares; Andrea Beatrice Santos da Silva; Lucas Salomão de Sousa Ferreira; Jorim Severino Ithamar; Guilherme de Alencar Medeiros; Silma Regina Ferreira Pereira; Mayara Ingrid Sousa Lima; Conceição de Maria Pedrozo E Silva de Azevedo
Journal:  Am J Trop Med Hyg       Date:  2020-09       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.